Long-term glucagon-like peptide-1 (GLP-1) therapies combined with intensive behavioral therapy are recommended for adults with obesity.

Facing increasing liability costs, Blue Mountain Heart to Heart will not renew its medical and behavioral health services ...

Medline has put forward terms for an absolutely massive IPO, which could see the medical device manufacturing and ...

As people with type 1 diabetes live longer than ever before, both clinicians and patients are recognizing the need to prepare ...

Doctors say the class of medications that includes Ozempic and Zepbound still offers health benefits for people with diabetes ...

Socioeconomic vulnerability and multiple medical comorbidities are risk factors for late-onset depression among long-term ...

That and other non-fruit related high jinks are afoot as the stars of The Pitt mingle on a backstage set for Entertainment ...

Federal Health Minister Mark Butler says it will now be up to the premiers and Anthony Albanese to strike a national hospital ...

Around 2.2 million Australians were living with a long-term neurological condition in 2022 with migraine the most ...

The study, which clocked wait times for common types of surgery and medically necessary elective specialist treatments across ...

A new WHO guideline on GLP-1s and recent efforts to reduce the drugs’ costs now and going forward are unlikely to change US ...

Screening pregnant women at 36 weeks using a validated risk model and offering risk-stratified planned early-term birth ...